{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:14:01Z","timestamp":1790259241607,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370407"],"award-info":[{"award-number":["81370407"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270267"],"award-info":[{"award-number":["81270267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300212"],"award-info":[{"award-number":["81300212"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Hubei Province of China","award":["2017CFB170"],"award-info":[{"award-number":["2017CFB170"]}]},{"name":"United Research Fund of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","award":["0203201702"],"award-info":[{"award-number":["0203201702"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.clim.2018.02.012","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T03:46:46Z","timestamp":1519703206000},"page":"98-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["A novel PADRE-Kv1.3 vaccine effectively induces therapeutic antibodies and ameliorates experimental autoimmune encephalomyelitis in rats"],"prefix":"10.1016","volume":"193","author":[{"given":"Cheng","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2018.02.012_bb0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2018.02.012_bb0010","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2018.02.012_bb0015","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.1073\/pnas.241497298","article-title":"Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis","volume":"98","author":"Beeton","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2018.02.012_bb0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11481-015-9614-0","article-title":"Multiple sclerosis and T lymphocytes: an entangled story","volume":"10","author":"Legroux","year":"2015","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.clim.2018.02.012_bb0025","doi-asserted-by":"crossref","first-page":"29479","DOI":"10.1074\/jbc.M112.379594","article-title":"Selective inhibition of CCR7(\u2212) effector memory T cell activation by a novel peptide targeting Kv1.3 channel in a rat experimental autoimmune encephalomyelitis model","volume":"287","author":"Li","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2018.02.012_bb0030","doi-asserted-by":"crossref","first-page":"10249","DOI":"10.1016\/j.biomaterials.2013.09.019","article-title":"Functionalized liposomes loaded with siRNAs targeting ion channels in effector memory T cells as a potential therapy for autoimmunity","volume":"34","author":"Hajdu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.clim.2018.02.012_bb0035","doi-asserted-by":"crossref","first-page":"948976","DOI":"10.1155\/2013\/948976","article-title":"The benefits and detriments of macrophages\/microglia in models of multiple sclerosis","volume":"2013","author":"Rawji","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.clim.2018.02.012_bb0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm1177","article-title":"Experimental autoimmune encephalomyelitis repressed by microglial paralysis","volume":"11","author":"Heppner","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2018.02.012_bb0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuint.2006.04.002","article-title":"Microglia and the control of autoreactive T cell responses","volume":"49","author":"Melchior","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.clim.2018.02.012_bb0050","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jnr.20488","article-title":"Microglial cell activation and proliferation precedes the onset of CNS autoimmunity","volume":"81","author":"Ponomarev","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.clim.2018.02.012_bb0055","doi-asserted-by":"crossref","first-page":"208093","DOI":"10.1155\/2013\/208093","article-title":"Role of microglia in CNS autoimmunity","volume":"2013","author":"Goldmann","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.clim.2018.02.012_bb0060","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1523\/JNEUROSCI.1251-05.2005","article-title":"Microglia Kv1.3 channels contribute to their ability to kill neurons","volume":"25","author":"Fordyce","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clim.2018.02.012_bb0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.mcn.2006.08.009","article-title":"The potassium channels Kv1.5 and Kv1.3 modulate distinct functions of microglia","volume":"33","author":"Pannasch","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.clim.2018.02.012_bb0070","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0605136103","article-title":"Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases","volume":"103","author":"Beeton","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2018.02.012_bb0075","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI16921","article-title":"The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS","volume":"111","author":"Wulff","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.clim.2018.02.012_bb0080","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1471-4159.2007.04889.x","article-title":"Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression","volume":"103","author":"Nutile-McMenemy","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.clim.2018.02.012_bb0085","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.4049\/jimmunol.1103095","article-title":"Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis","volume":"188","author":"Gocke","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.02.012_bb0090","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1517\/14728222.2016.1112792","article-title":"The voltage-gated potassium channel Kv1.3 is a promising multitherapeutic target against human pathologies","volume":"20","author":"Perez-Verdaguer","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.clim.2018.02.012_bb0095","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-016-8263-4","article-title":"Vaccines and multiple sclerosis: a systematic review","volume":"264","author":"Mailand","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2018.02.012_bb0100","doi-asserted-by":"crossref","first-page":"e36379","DOI":"10.1371\/journal.pone.0036379","article-title":"The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2018.02.012_bb0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1194\/jlr.M023846","article-title":"Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL","volume":"54","author":"Yang","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clim.2018.02.012_bb0110","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4049\/jimmunol.164.3.1625","article-title":"Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses","volume":"164","author":"Alexander","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.02.012_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ymeth.2011.12.001","article-title":"Production and characterization of peptide antibodies","volume":"56","author":"Trier","year":"2012","journal-title":"Methods"},{"key":"10.1016\/j.clim.2018.02.012_bb0120","doi-asserted-by":"crossref","first-page":"e0120165","DOI":"10.1371\/journal.pone.0120165","article-title":"Evaluation of arecoline hydrobromide toxicity after a 14-day repeated oral administration in Wistar rats","volume":"10","author":"Wei","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2018.02.012_bb0125","first-page":"285245","article-title":"The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"2014","author":"Duffy","year":"2014","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.clim.2018.02.012_bb0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jneuroim.2014.01.006","article-title":"Therapeutic effects of nonerythropoietic erythropoietin analog ARA290 in experimental autoimmune encephalomyelitis rat","volume":"268","author":"Chen","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2018.02.012_bb0135","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1084\/jem.20080730","article-title":"CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells","volume":"205","author":"Meiron","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2018.02.012_bb0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1742-2094-8-149","article-title":"Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis","volume":"8","author":"Virgili","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2018.02.012_bb0145","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nm.1980","article-title":"Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system","volume":"15","author":"Schulze-Topphoff","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2018.02.012_bb0150","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.imbio.2013.04.004","article-title":"High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis","volume":"218","author":"Blazevski","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.clim.2018.02.012_bb0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.expneurol.2014.05.013","article-title":"Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis","volume":"261","author":"Jiang","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.clim.2018.02.012_bb0160","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1517\/14656566.2015.1002769","article-title":"Effectiveness of multiple sclerosis treatment with current immunomodulatory drugs","volume":"16","author":"Milo","year":"2015","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.clim.2018.02.012_bb0165","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.clinthera.2014.08.006","article-title":"Update on disease-modifying treatments for multiple sclerosis","volume":"36","author":"Carrithers","year":"2014","journal-title":"Clin. Ther."},{"key":"10.1016\/j.clim.2018.02.012_bb0170","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.clinthera.2015.03.001","article-title":"New FDA-approved disease-modifying therapies for multiple sclerosis","volume":"37","author":"English","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.clim.2018.02.012_bb0175","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/j.lpm.2015.02.008","article-title":"Update on treatments in multiple sclerosis","volume":"44","author":"Michel","year":"2015","journal-title":"Presse Med."},{"key":"10.1016\/j.clim.2018.02.012_bb0180","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.addr.2005.11.003","article-title":"Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy","volume":"58","author":"van der Burg","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.clim.2018.02.012_bb0185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00023210-200822030-00001","article-title":"Vaccines for multiple sclerosis: progress to date","volume":"22","author":"Correale","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clim.2018.02.012_bb0190","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0264-410X(97)00186-2","article-title":"Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo","volume":"15","author":"del Guercio","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2018.02.012_bb0195","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s12031-015-0643-1","article-title":"Molecular mechanisms of the action of vitamin A in Th17\/Treg axis in multiple sclerosis","volume":"57","author":"Abdolahi","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.clim.2018.02.012_bb0200","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3109\/08923973.2011.619987","article-title":"The deviated balance between regulatory T cell and Th17 in autoimmunity","volume":"34","author":"Jadidi-Niaragh","year":"2012","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.clim.2018.02.012_bb0205","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1016\/j.vaccine.2014.08.016","article-title":"Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis","volume":"32","author":"Cappellano","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2018.02.012_bb0210","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fimmu.2015.00492","article-title":"Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"6","author":"Arellano","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2018.02.012_bb0215","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.02.012_bb0220","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1038\/ncomms6101","article-title":"NAD+ protects against EAE by regulating CD4+ T-cell differentiation","volume":"5","author":"Tullius","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2018.02.012_bb0225","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2018.02.012_bb0230","doi-asserted-by":"crossref","first-page":"e54841","DOI":"10.1371\/journal.pone.0054841","article-title":"Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2018.02.012_bb0235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/1352458510379243","article-title":"Altered M1\/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration","volume":"17","author":"Mikita","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clim.2018.02.012_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.02.003","article-title":"The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis","volume":"127-128","author":"Mallucci","year":"2015","journal-title":"Prog. Neurobiol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617309130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617309130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T20:25:10Z","timestamp":1535055910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661617309130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":48,"alternative-id":["S1521661617309130"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.02.012","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel PADRE-Kv1.3 vaccine effectively induces therapeutic antibodies and ameliorates experimental autoimmune encephalomyelitis in rats","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}